SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that Anthem has issued a positive coverage decision for the Prosigna® Breast Cancer Gene Signature Assay.  This positive coverage decision is in line with updated ASCO guidelines released in February 2016.  The ASCO guidelines recommend the use of […]

Oxford Nanopore has released a new basecaller, Albacore v2.0.1, that identifies DNA sequences directly from raw data, rather than utilising an intermediary stage called ‘event detection’. This upgrade enhances accuracy of the single-read sequence data, contributing to high consensus accuracy for nanopore sequence data. Moving to raw basecalling also opens up opportunities for further improvements […]

LANSING, Mich. — Neogen Corporation (NASDAQ: NEOG) announced today that it has acquired the assets of The University of Queensland Animal Genetics Laboratory (AGL) — the leading animal genomics laboratory in Australia, a country with large cattle and sheep markets. The acquisition of AGL is intended to help accelerate the growth of Neogen’s animal genomics […]

Seoul, Korea – Seegene, the world’s leading developer of multiplex molecular technologies and assays, announced that it has recently signed collaborative contracts with 30 general hospitals and reference laboratories across 15 nations for the co-development of ‘Project 100’ products. Contracting parties are mostly the largest commercial labs in the country, university hospitals, and institutions with […]

Company expands portfolio of next-generation sequencing immuno-oncology and liquid biopsy assays to meet demand for a multi-disciplinary approach to cancer research AMSTERDAM and MADRID and CARLSBAD, Calif. — Thermo Fisher Scientific has formed the Immuno-Oncology Consortium to drive adoption of highly sensitive, next-generation sequencing (NGS) clinical research panels designed to help identify predictive and prognostic biomarkers associated with cancer immunotherapy. Recognizing […]

Recent market developments inspire ExcitePCR management to expand its product strategy to a planned rollout of a FireflyDX family of realtime pathogen detection systems, with the FireflyDX-Portable launch scheduled for the summer of 2018 and the FireflyDX-Handheld targeted for availability in 2019 Pleasanton, Calif. ExcitePCR™ today announced the FireflyDX-Portable™, a rechargeable bookbag-sized realtime pathogen detection […]

Purchase of PMR and creation of Hygiena Mexico establishes permanent base in Mexico City   Hygiena, a Warburg Pincus portfolio company that specializes in rapid food safety and environmental sanitation testing, today announced that it has acquired Pruebas Microbiologicas Rapidas (PMR), a Mexico City-based distributor that has long served as an independent partner of Hygiena […]

New Food Safety Studio in Bellevue, Washington, serves as global center for innovation and collaboration Demonstration and training lab space extends product and process development to customers Billerica, Massachusetts — MilliporeSigma has opened its first global Food Safety Studio in Bellevue, Washington for manufacturers of all types of food (beef, poultry, produce, etc.) to collaborate with MilliporeSigma scientists […]

DELRAY BEACH, Fla. — PositiveID Corporation(OTCQB:PSID), a life sciences company focused on detection and diagnostics, today announced that its subsidiary, ExcitePCR Corporation, has hired David L. Politis as its Chief Marketing & Sales Officer. In his role as CMSO, Politis will direct and implement all marketing, sales and business development efforts for ExcitePCR as it prepares […]

Independent new company will accelerate development of Illumina’s forensic genomics technologies to enable more insight than traditional methods SAN DIEGO —- Illumina, Inc. (NASDAQ: ILMN) today announced plans with Telegraph Hill Partners (THP), a San Francisco-based venture capital and growth equity firm, to establish Verogen, Inc. The independent new company has certain exclusive rights to provide Illumina’s forensic sequencing technology to forensic customers, […]